Concepedia

Author

Mark Kačar

Leeds Teaching Hospitals NHS TrustORCID

Also Known As

Kacar M, Kacar, Mark, M Kacar, M Kaçar, M. Kacar, M., Kačar, Mark Kacar, Mark Kačar

39

Publications

2.5K

Citations

14

H-Index

19

Concepts

All Affiliations

Leeds Teaching Hospitals NHS TrustKing's College LondonUniversity of LeedsSt James's University HospitalUniversity of Nottingham
MK

About

Mark Kačar is an author at Leeds Teaching Hospitals NHS Trust specializing in medicine, covid-19, and allergy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

950

2

Allergy

1

1

13

3

Hospital Medicine

1

1

555

4

Immunology

1

1

13

5

Pathology

1

1

13

Mark Kačar

×

12

Publications

2K

Citations

12

H-Index

YearCitations

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi,

The Lancet

2021

555

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas,

The Lancet

2021

516

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas,

The Lancet

2022

382

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas,

The Lancet

2021

289

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas,

The Lancet

2023

126

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas,

The Lancet Diabetes & Endocrinology

2023

34

Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication

‬‬‬‬Abdulla Watad, Mark Kačar, Nicola Luigi Bragazzi,

Frontiers in Immunology

2021

31

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones,

The Lancet Child & Adolescent Health

2024

31

Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease

Mark Kačar, John Fitton, Andrew Gough,

RMD Open

2020

27

High burden of clonal mast cell disorders and hereditary α‐tryptasemia in patients who need <i>Hymenoptera</i> venom immunotherapy

Peter Korošec, Gunter J. Sturm, Jonathan J. Lyons,

Allergy

2024

25

Page 1